Minireview
Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics and antidepressants

https://doi.org/10.1016/0024-3205(92)90001-6Get rights and content

Abstract

Several classes of drugs that modify serotonin (5-HT) neurotransmission are either currently used, or are being evaluated for their potential use in the treatment of anxiety, schizophrenia, and depression. 5-HT1A agonists are considered potential anxiolytics, while some atypical antipsychotics are potent 5-HT2 antagonists (and also have modest dopamine D2 affinity). Furthermore, there is a diverse group of serotonergic drugs that may be effective antidepressants. Secretion of ACTH, corticosterone/cortisol, prolactin, renin, oxytocin and vasopressin are stimulated by activation of different 5-HT receptor subtypes, while other neurotransmitter receptors also influence the secretion of these hormones. We compared the receptor binding profiles of 5-HT anxiolytics, antipsychotics and antidepressants with their endocrine effects. These comparisons could aid in understanding both the therapeutic and side effects of these drugs.

References (124)

  • J.S. Sprouse et al.

    Neuropharmacology

    (1988)
  • J.S. Sprouse et al.

    Eur. J. Pharmacol.

    (1986)
  • J.T. Lum et al.

    Eur. J. Pharmacol.

    (1988)
  • A. Hamik et al.

    Biol. Psychiatry

    (1990)
  • I. Van Wijngaarden et al.

    Eur. J. Pharmacol.

    (1990)
  • M.J. Millan et al.

    Eur. J. Pharmacol.

    (1991)
  • K.J. Watling et al.

    Eur. J. Pharmacol.

    (1990)
  • P.H. Andersen

    Eur. J. Pharmacol.

    (1988)
  • F.J. Bolaños et al.

    Biochem. Pharmacol.

    (1990)
  • H. Canton et al.

    Eur. J. Pharmacol.

    (1990)
  • J.T. Haskins et al.

    Brain Res. Bull.

    (1987)
  • T.P. Blackburn et al.

    Eur. J. Pharmacol.

    (1988)
  • D.T. Wong et al.

    Biochem. Pharmacol.

    (1983)
  • Y. Itzhak et al.

    Neuropharmacology

    (1990)
  • L.P. Renaud et al.

    Prog. Neurobiol.

    (1991)
  • N. Falke

    Prog. Neurobiol.

    (1991)
  • A.W. Zuardi

    Neurosci. Biobehav. Rev.

    (1990)
  • R.S. Kahn et al.

    Biol. Psychiatry

    (1991)
  • P.E. Stokes et al.

    Endocrinol. Metab. Clin. North Am.

    (1988)
  • G.C. Curtis et al.

    Endocrinol. Metab. Clin. North Am.

    (1988)
  • D.L. Garver

    Endocrinol. Metab. Clin. North Am.

    (1988)
  • C.F. Saller et al.

    Eur. J. Pharmacol.

    (1986)
  • J.A. Apud et al.

    Psychoneuroendocrinology

    (1984)
  • J. Traber et al.

    Trends Pharm. Sci.

    (1987)
  • G. Bianchi et al.

    Eur. J. Pharmacol.

    (1988)
  • B. Costall et al.

    Pharmacol. Ther.

    (1990)
  • F. Gilbert et al.

    Eur. J. Pharmacol.

    (1988)
  • J.H. Urban et al.

    Pharmacol. Biochem. Behav.

    (1986)
  • M.J. Owens et al.

    Eur. J. Pharmacol.

    (1990)
  • G.K. Matheson et al.

    Neuropharmacology

    (1989)
  • L.D. Van De Kar et al.

    Neuropharmacology

    (1985)
  • L. Krulich

    Life Sci.

    (1975)
  • D.M. Gibbs et al.

    Brain Research

    (1983)
  • R.W. Fuller et al.

    Neuropharmacology

    (1984)
  • F. Gilbert et al.

    Eur. J. Pharmacol.

    (1988)
  • N. Ben-Jonathan et al.

    Prog. Neurobiol.

    (1989)
  • L.D. Van De Kar et al.

    Life Sci.

    (1985)
  • V. Baudrie et al.

    Eur. J. Pharmacol.

    (1991)
  • S.E. File

    Pharmacol. Ther.

    (1990)
  • P.P. Roy-Byrne et al.

    Biol. Psychiatry

    (1991)
  • M.G. Monteiro et al.

    Biol. Psychiatry

    (1990)
  • J.S. Sprouse et al.

    Synapse

    (1987)
  • S. Hjorth et al.

    Naunyn-Schmiedeberg's Arch. Pharmacol.

    (1988)
  • D. Hoyer

    J. Receptor Research

    (1988)
  • S.J. Offord et al.

    J. Pharmacol. Exp. Ther.

    (1988)
  • J. Svartengren et al.

    Pharmacol. Toxicol.

    (1990)
  • C.F. Saller et al.

    J. Pharmacol. Exp. Ther.

    (1990)
  • E.G. Christensson

    Acta psychiat. Scand.

    (1989)
  • D.T. Wong et al.

    Neuropsychopharmacology

    (1991)
  • D. McTavish et al.

    Drugs

    (1990)
  • Cited by (0)

    View full text